![](/img/cover-not-exists.png)
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
Barber, Emma L., Zsiros, Emese, Lurain, John R., Rademaker, Alfred, Schink, Julian C., Neubauer, Nikki L.Volume:
24
Year:
2013
Language:
english
Journal:
Journal of Gynecologic Oncology
DOI:
10.3802/jgo.2013.24.3.258
File:
PDF, 292 KB
english, 2013